# Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

> **NCT07403266** · PHASE3 · RECRUITING · sponsor: **Oils4Cure** · enrollment: 84 (estimated)

## Conditions studied

- Tuberous Sclerosis Complex (TSC)

## Interventions

- **DRUG:** YCJ-01 Full Spectrum cannbis Extract
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07403266
- **Lead sponsor:** Oils4Cure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-06
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07403266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07403266, "Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07403266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*